Welcome to AdWatch

2007

           August: Response to criticism of Adwatch on Avandia (March Adwatch)

           June: Arthritis advertorial by Pfizer published in the Australian edition of the Readers Digest in March 2007.

See also judgement by Medicines Australia re 'Code of Conduct complaints relating to activities directed at the general public January - May 2007'

           March: Do not ADOPT rosiglitazone as first-line diabetes treatment. Avandia from GSK.

2006

           December: 'Use the best first'. Moxafloxacin from Bayer (Italy)

           September: Antidepressants are not sweets. Efexor™ Tetrapacks

           July: 'Don't give him the usual treatment'.   Lipidil™ (fenofibrate) from Solvay/Fournier

           May: She needs safe and reliable contraception, not a treatment for severe acne! EstelleTM-35ED from  Douglas

                         (see also: Corrective Letter from Douglas)

2004

August: Feedback about AdWatch on Micardis Plus

June: "The early morning danger zone":
Micardis Plus (telmisartan plus hydrochlorothiazide) from Boehringer Ingelheim

April: Dialogue about AdWatch on Nexium

March: Feedback about AdWatch on Augmentin

February: "Take a closer look": Augmentin (amoxicillin with potassium clavulanate) from GlaxoSmithKline

2003

December: Feedback on Nexium (esomeprazole) from AstraZeneca

October: Nexium (esomeprazole) from AstraZeneca